Cefamandole

Therapeutic Indications

Cefamandole is indicated for:

at least one of
at least one of
Streptococcus pneumoniae

Haemophilus influenzae

Klebsiella pneumoniae

Staphylococcus aureus

Proteus mirabilis

Staphylococcus haemolyticus
and additionally
Respiratory tract infection

Pneumonia due to Klebsiella pneumoniae

Pneumonia due to staphylococcus

Pneumonia due to streptococcus, group B

Pneumonia due to other streptococci

Pneumonia due to Escherichia coli

at least one of
Escherichia coli

Proteus mirabilis

Enterobacter

Klebsiella

Streptococcus, group D
and additionally
Urinary tract infectious disease

Acute peritonitis
and additionally at least one of
Escherichia coli

Enterobacter

Sepsis
and additionally at least one of
Escherichia coli

Staphylococcus aureus

Streptococcus pneumoniae

Beta-hemolytic Streptococcus, group A

Haemophilus influenzae

Klebsiella

Infection of skin
and additionally at least one of
Staphylococcus aureus

Beta-hemolytic Streptococcus, group A

Haemophilus influenzae

Escherichia coli

Enterobacter

Proteus mirabilis

Musculoskeletal infective disorder
and additionally
Staphylococcus aureus

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intramuscular

Treatment 2: Intravenous

at least one of
at least one of
Streptococcus pneumoniae

Haemophilus influenzae

Klebsiella pneumoniae

Staphylococcus aureus

Proteus mirabilis

Staphylococcus haemolyticus
and additionally
Respiratory tract infection

Pneumonia due to Klebsiella pneumoniae

Pneumonia due to staphylococcus

Pneumonia due to streptococcus, group B

Pneumonia due to other streptococci

Pneumonia due to Escherichia coli

at least one of
Escherichia coli

Proteus mirabilis

Enterobacter

Klebsiella

Streptococcus, group D
and additionally
Urinary tract infectious disease

Acute peritonitis
and additionally at least one of
Escherichia coli

Enterobacter

Sepsis
and additionally at least one of
Escherichia coli

Staphylococcus aureus

Streptococcus pneumoniae

Beta-hemolytic Streptococcus, group A

Haemophilus influenzae

Klebsiella

Infection of skin
and additionally at least one of
Staphylococcus aureus

Beta-hemolytic Streptococcus, group A

Haemophilus influenzae

Escherichia coli

Enterobacter

Proteus mirabilis

Musculoskeletal infective disorder
and additionally
Staphylococcus aureus

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intramuscular

Treatment 2: Intravenous

Contraindications

Active ingredient Cefamandole is contraindicated in the following cases: